This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
5 Stocks to Add to Your Portfolio on Upgraded Broker Ratings
by Zacks Equity Research
After proper research, brokers rate a particular company's stock. So, you can easily depend on their recommendations before making investment decision.
Veeva Systems' Development Cloud Platform Picked by Idorsia
by Zacks Equity Research
Switzerland's Idorsia implements Veeva Systems' (VEEV) Development Cloud. Veeva Systems gains foothold in Europe.
Integer Holdings (ITGR) Catches Eye: Stock Jumps 7.5%
by Zacks Equity Research
Integer Holdings (ITGR) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Here's Why You Should Invest in DaVIta (DVA) Stock Right Now
by Zacks Equity Research
Strong fundamentals and solid international presence make DaVita (DVA) a lucrative pick.
ITGR vs. ABMD: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ITGR vs. ABMD: Which Stock Is the Better Value Option?
Zacks.com highlights: Movado Group, BRT Apartments, Integer Holdings, Hollysys Automation Technologies and QuinStreet
by Zacks Equity Research
Zacks.com highlights: Movado Group, BRT Apartments, Integer Holdings, Hollysys Automation Technologies and QuinStreet
5 Stocks to Buy on New Analyst Coverage
by Zacks Equity Research
More analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.
Walgreens Boots (WBA) Grows on New Pacts Amid Several Woes
by Zacks Equity Research
Walgreens Boots' (WBA) alliance with Express Scripts is expected to expand both companies' existing group purchasing efforts.
3 Undervalued MedTech Stocks to Stay Safe From Trade War
by Sreyoshi Mukherjee
Amid U.S. market turmoil, a few stocks from the MedTech industry can prove profitable over the long haul.
MASI or STE: Which Is a Better Investment Option Right Now?
by Zacks Equity Research
Masimo's (MASI) and STERIS' (STE) strong expected growth rates and impressive price performance make them close contenders in the Medical Instruments space.
Insulet Omnipod Insulin Pump Finds Favor in British Columbia
by Zacks Equity Research
Insulet's (PODD) Omnipod has huge market potential in Canada as it is the only tubeless insulin pump sold in the region.
Here's Why You Should Invest in Masimo (MASI) Right Now
by Zacks Equity Research
Masimo's (MASI) raised guidance for 2018 and strong fundamentals make it a lucrative pick.
Integer Holdings Offloads AS&O, Focuses on Cardiac Units
by Zacks Equity Research
Integer Holdings (ITGR) divests core AS&O unit to MedPlast, LLC for $600 million; aims to focus on cardiac business.
MOHAP Selects Masimo's (MASI) Eve for CCHD Screening in UAE
by Zacks Equity Research
Masimo's (MASI) Eve with Rad-97 Pulse CO-Oximeter to be integrated in nine hospitals across UAE for CCHD screening in newborns.
Walgreens (WBA) Tops Q3 Earnings Estimates, Narrows View
by Zacks Equity Research
Walgreens Boots (WBA) is upbeat about the recent acquisition of stores from Rite Aid which has already started to strengthen its U.S. pharmacies business.
Stryker (SYK) to Acquire SafeAir, Reduce Surgical Smoke
by Zacks Equity Research
The acquisition of SafeAir likely to boost Stryker's (SYK) core MedSurg and Neurotechnology segments.
Here's Why You Should Steer Clear of Fresenius Medical Now
by Zacks Equity Research
Soft segmental performance and a downbeat revenue guidance reflect Fresenius Medical's (FMS) weaknesses.
Medical Device Firms in Focus on Expanded R&D Scope: 5 Picks
by Zacks Equity Research
The suspension of the Medical Device Tax, the evolution of mechatronics and big data in the MedTech space make some of the stocks lucrative picks for investment.
ITGR vs. GMED: Which Stock Is the Better Value Option?
by Zacks Equity Research
ITGR vs. GMED: Which Stock Is the Better Value Option?
ISRG or ITGR: Which is a Better Medical Instrument Stock?
by Zacks Equity Research
Intuitive Surgical (ISRG) and Integer Holdings' (ITGR) strong fundamentals and rising share price make them close contenders.
3 Medical Instrument Stocks to Gain on Solid Market Prospects
by Zacks Equity Research
Here we take a peek at three Medical Instrument stocks that are likely to deliver strong returns in the days to come.
ITGR vs. GMED: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ITGR vs. GMED: Which Stock Is the Better Value Option?
Integer Holdings (ITGR) Up 18.9% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Integer Holdings (ITGR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Surmodics (SRDX) Hits Fresh Highs: Is There Still Room to Run?
by Zacks Equity Research
Surmodics, Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for SRDX for clues.
IDEXX (IDXX) Hits a 52-Week High, Can the Run Continue?
by Zacks Equity Research
IDEXX Laboratories, Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for IDXX for clues.